Not applicableStudy completedNCT02834234What this trial is testingGenomic Analysis of Peritoneal Mesothelioma by CGH ArraysWho this might be right forPeritoneal Mesothelioma Hospices Civils de Lyon 33
Testing effectiveness (Phase 2)Ended earlyNCT05500508What this trial is testingOral AMXT 1501 Dicaprate in Combination With IV DFMOWho this might be right forCancerSolid TumorSolid Carcinoma+17 more Aminex Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00996385What this trial is testingVelcade and Eloxatin for Patients With Malignant Pleural or Peritoneal MesotheliomaWho this might be right forMesothelioma Columbia University 29
Not applicableStudy completedNCT01812148What this trial is testingSurvival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)Who this might be right forPeritoneal Mesotheliomas Maisonneuve-Rosemont Hospital 19
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Testing effectiveness (Phase 2)Study completedNCT05041062What this trial is testingImmunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal MesotheliomaWho this might be right forMesotheliomaPeritoneal Mesothelioma University of Chicago 2
Testing effectiveness (Phase 2)Temporarily pausedNCT03875144What this trial is testingTreatment of Malignant Peritoneal Mesothelioma (MESOTIP)Who this might be right forPeritoneal MesotheliomaPeritoneal Carcinomatosis Institut du Cancer de Montpellier - Val d'Aurelle 66
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT03054298What this trial is testingCAR T Cells in Mesothelin Expressing CancersWho this might be right forLung AdenocarcinomaOvarian CancerPeritoneal Carcinoma+3 more University of Pennsylvania 65
Testing effectiveness (Phase 2)Study completedNCT05455424What this trial is testingNiraparib Efficacy in Patient With Unresectable MesotheliomaWho this might be right forMesothelioma, Malignant University Hospital Southampton NHS Foundation Trust 88
Testing effectiveness (Phase 2)Study completedNCT01160458What this trial is testingPhase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With ChemotherapyWho this might be right forPleural MesotheliomaPeritoneal Mesothelioma National Cancer Institute (NCI) 20
Not applicableStudy completedNCT03867578What this trial is testingMagnetic Resonance Imaging for Detection of Peritoneal MesotheliomaWho this might be right forMesotheliomaPeritoneal Mesothelioma University of Chicago 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT01843374What this trial is testingRandomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant MesotheliomaWho this might be right forUnresectable Pleural or Peritoneal Malignant Mesothelioma MedImmune LLC 571
Not applicableEnded earlyNCT00028782What this trial is testingEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerWho this might be right forAdvanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02535312What this trial is testingMethoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or CarboplatinWho this might be right forAdvanced Malignant Solid NeoplasmAdvanced Peritoneal Malignant MesotheliomaAdvanced Pleural Malignant Mesothelioma+4 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00003046What this trial is testingInterleukin-12 in Treating Patients With Cancer in the AbdomenWho this might be right forAnal CancerColorectal CancerGallbladder Cancer+2 more M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT05449366What this trial is testingIntraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal MesotheliomaWho this might be right forPeritoneal Malignant Mesothelioma Erasmus Medical Center 7
Early research (Phase 1)Ended earlyNCT03608618What this trial is testingIntraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal MesotheliomaWho this might be right forPeritoneal MesotheliomaFallopian Tube AdenocarcinomaAdenocarcinoma of the Ovary+1 more MaxCyte, Inc. 14